ストックスクリーナーアプリを入手
15.79
1.31%
-0.21
アフターアワーズ：
15.80
0.01
+0.06%
前日終値:
$16.00
開ける：
$15.9
24時間の取引高:
83,848
Relative Volume:
0.34
時価総額：
$2.04B
収益：
$65.48M
当期純損益:
$-94.46M
株価収益率:
-21.41
EPS:
-0.7375
ネットキャッシュフロー:
$-71.18M
1週間 パフォーマンス:
+3.75%
1か月 パフォーマンス:
+6.62%
6か月 パフォーマンス:
+1.61%
1年 パフォーマンス:
+39.73%
1日の値動き範囲:
$15.62
$16.00
1週間の範囲:
$15.19
$16.06
52週間の値動き範囲:
$9.88
$21.50
Mesoblast Ltd Adr Stock (MESO) Company Profile
Compare MESO vs VRTX, REGN, ARGX, ALNY, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
MESO
Mesoblast Ltd Adr
|
15.79 | 2.07B | 65.48M | -94.46M | -71.18M | -0.7375 |
VRTX
Vertex Pharmaceuticals Inc
|
424.36 | 109.34B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
702.27 | 74.35B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
794.70 | 50.44B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
301.11 | 39.78B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
297.49 | 33.02B | 5.36B | 287.73M | 924.18M | 2.5229 |
Mesoblast Ltd Adr Stock (MESO) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-11-25 | アップグレード | Jefferies | Hold → Buy |
| 2025-07-18 | ダウングレード | Jefferies | Buy → Hold |
| 2024-12-23 | ダウングレード | Jefferies | Buy → Hold |
| 2024-09-24 | アップグレード | Maxim Group | Hold → Buy |
| 2024-08-29 | アップグレード | Jefferies | Hold → Buy |
| 2024-07-23 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2023-08-31 | アップグレード | Jefferies | Hold → Buy |
| 2023-08-07 | ダウングレード | Maxim Group | Buy → Hold |
| 2023-08-04 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2023-08-04 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2023-03-09 | 開始されました | William Blair | Outperform |
| 2022-12-06 | ダウングレード | Jefferies | Buy → Hold |
| 2022-09-06 | 開始されました | Piper Sandler | Overweight |
| 2021-04-07 | アップグレード | Maxim Group | Hold → Buy |
| 2020-12-22 | ダウングレード | Maxim Group | Buy → Hold |
| 2020-12-04 | ダウングレード | Chardan Capital Markets | Neutral → Sell |
| 2020-10-22 | 開始されました | RBC Capital Mkts | Sector Perform |
| 2020-08-14 | 繰り返されました | Maxim Group | Buy |
| 2020-05-28 | 繰り返されました | H.C. Wainwright | Buy |
| 2019-01-31 | 再開されました | H.C. Wainwright | Buy |
| 2018-03-22 | ダウングレード | Credit Suisse | Neutral → Underperform |
| 2018-02-28 | 繰り返されました | Cantor Fitzgerald | Buy |
| 2017-08-31 | 開始されました | Oppenheimer | Outperform |
| 2017-06-08 | 開始されました | Cantor Fitzgerald | Buy |
すべてを表示
Mesoblast Ltd Adr (MESO) 最新ニュース
Mesoblast LimitedDepositary Receipt (MESO) price target decreased by 14.96% to 15.33 - MSN
Mesoblast Reports Ryoncil® Net Revenues of US$30.3m and Improved Net Operating Cash Spend for the Quarter to US$4.1 Million - GlobeNewswire Inc.
Mesoblast acquires CAR technology license from Mayo Clinic - Investing.com
FDA clears Mesoblast DMD trial for Ryoncil in children - Investing.com
Mesoblast drops after Ryoncil sales data for March quarter - Seeking Alpha
MESO Ignites 10% Surge: A Biotech Spark Ignited Without a Visible Fuse - Bitget
Philip Krause details Mesoblast (NASDAQ: MESO) share and option holdings - Stock Titan
Mesoblast issues 5 million unquoted warrants as fee for US$50 million convertible note facility - MSN
Mesoblast Ltd Stock (ISIN: AU000000MSB8) Faces Pressure as Director Buys Signal Confidence Amid Anal - AD HOC NEWS
Gregory George beneficial owner at Mesoblast (OTC: MEOBF) with 22.36% stake - Stock Titan
MEOBF SEC FilingsMesoblast 10-K, 10-Q, 8-K Forms - Stock Titan
Cell Therapies Moving From Lab to Factory Floor, and the Stocks Behind Them - Sahm
Earnings call transcript: Mesoblast’s strong Q1 2026 performance boosts outlook - Investing.com
FARM 51 GROUP S.A.ZY -,1.XFRA: MWBMUHANDELSUNTERBRECHUNGTEIL 5 - aktiencheck.de
Mesoblast stock reaches 52-week high at 21.05 USD - Investing.com
Mesoblast stock reaches 52-week high at 21.05 USD By Investing.com - Investing.com India
Mesoblast announces board leadership changes as company evolves - Investing.com South Africa
Mesoblast Issues 5 Million Unquoted Warrants as Fee for US$50 Million Convertible Note Facility - TipRanks
Mesoblast Shares (ASX:MSB) Stall at Resistance After Recent Rally - thebull.com.au
ETFs Investing in Mesoblast Limited Sponsored ADR Stocks - TradingView
Why Autodesk Shares Are Trading Higher By Around 6%; Here Are 20 Stocks Moving Premarket - inkl
Jefferies upgrades Mesoblast stock to Buy on strong Ryoncil sales - Investing.com
Mesoblast rides early ryoncil® momentum, tightens cash discipline, and prepares for next growth phase - Proactive financial news
Why CSX Shares Are Trading Higher By Over 4%; Here Are 20 Stocks Moving Premarket - Benzinga
Quantum Computing, Mesoblast And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga
Mesoblast secures up to US$50m in fresh funding through convertible note agreements - Biotech Dispatch
Mesoblast Secures Up To US$50 Mln In Convertible Note Agreements With Key Investors - Nasdaq
Canaccord Genuity initiates Mesoblast stock with Buy rating on cell therapy potential - Investing.com
Mesoblast stock soars after reporting first Ryoncil sales - Investing.com
Mesoblast Ltd (MSB) Stock Forecast & Analyst Ratings - Moomoo
Mesoblast Targets Accelerated FDA Approval For Heart Failure Drug Revascor - Sahm
Why Cheetah Mobile Shares Are Trading Higher By Over 11%; Here Are 20 Stocks Moving Premarket - Benzinga
All Markets & Instruments Available to Trade - Capital.com
ASX Lunch Wrap: ASX and gold reset record highs; but Origin cuts its LNG forecast - Stockhead
Why are Mesoblast shares in a trading halt? - The Motley Fool Australia
ASX healthcare 2024 winners and losers, plus what’s next for 2025 - Stockhead
Mesoblast After Approval: Stock Is Buoyant Now, But Unpredictable Overall (NASDAQ:MESO) - Seeking Alpha
Mesoblast Finally Gets Its Approval In GVHD: Where Now? (NASDAQ:MESO) - Seeking Alpha
Invesco Nasdaq Biotechnology ETF Holdings - Quiver Quantitative
Mesoblast: Undervalued Due To Remestemcel-L's Substantial Growth Potential (NASDAQ:MESO) - Seeking Alpha
MESOMesoblast Ltd ADR Short Interest - Finviz
Mesoblast Limited: Back From The Dead (NASDAQ:MESO) - Seeking Alpha
Why Westport Fuel Systems Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session - TradingView — Track All Markets
symbol__ Stock Quote Price and Forecast - CNN
Mesoblast Ltd Share Price ADR Each Representing 10 Ord Shares SPON - Hargreaves Lansdown
Recent Insider BuyingStock ScreenerSnapshot - Finviz
What is the current Price Target and Forecast for Mesoblast Limited (MESO) - Zacks Investment Research
Mesoblast Ltd Adr (MESO) 財務データ
収益
当期純利益
現金流量
EPS
0.14%
0.48%
大文字化:
|
ボリューム (24 時間):